Health & Fitness

According to FutureWise analysis the orthokeratology contact lens market in 2025 is US$ 791.4 million, and is expected to reach US$ 1342.8 million by 2033 at a CAGR of 6.83%. The expansion of the vision correction market is primarily influenced by the increasing rates of myopia, particularly in children and young adults. This trend is complemented by a greater acceptance of non-surgical methods for vision correction. Furthermore, advancements in lens design and materials, coupled with heightened awareness of the effectiveness of orthokeratology in controlling myopia, are significantly contributing to the growth of this market. Orthokeratology contact lenses, often referred to as Ortho-K, OK, corneal reshaping, corneal refractive therapy, or vision shaping treatment, represent an innovative approach for correcting refractive errors. This technique utilizes custom-designed rigid lenses to temporarily modify the curvature of the cornea. Modern advances in Ortho-K technology feature ... Continue reading →

According to FutureWise analysis the Orthopedic Bone Cement Market in 2025 is US$ 0.82 billion, and is expected to reach US$ 1.38 billion by 2033 at a CAGR of 6.72%. The market is growing due to the increasing number of joint replacement surgeries, advancements in minimally invasive procedures, and a rising geriatric population susceptible to osteoarthritis and osteoporosis. Innovations in antibiotic-loaded bone cements are also improving infection control in revision surgeries, driving demand even higher. Polymethylmethacrylate, commonly referred to as bone cement, plays a crucial role in securing implants during various dental, orthopedic, and trauma surgeries. While it does not possess intrinsic adhesive properties, its effectiveness relies on the mechanical interlocking between the prosthesis and the irregular surface of the bone. Bone cement is available in several forms, including Glass Polyalkenoate (ionomer) cement (GPC) and Calcium Phosphate Cement (CPC). The latter is ... Continue reading →

According to FutureWise analysis the Orthopedic Prosthetics Market in 2025 is US$ 2.43 billion, and is expected to reach US$ 4.67 billion by 2033 at a CAGR of 8.51%.The market is experiencing growth due to an increase in limb amputations caused by trauma, vascular diseases, and diabetes. There is also a rising demand for advanced, lightweight options. Innovations such as myoelectric and 3D-printed prosthetics are enhancing mobility and improving the quality of life for users, which is further driving the market expansion. Orthopedic prosthetic devices play a crucial role in supporting the identification, design, production, and fitting of custom-made artificial limbs for individuals who have lost part of a limb due to various reasons, including disease, trauma, or congenital defects. The growing prevalence of orthopedic injuries and chronic conditions causing bone deformities is driving the demand for orthopedic prosthetics. Several factors are contributing to the advancement of the ... Continue reading →

Actigraphy Sensors and PSG Devices Market By Product Type, By Technology Type, By Distribution Channel and By Region: Industry Analysis, Market Share, Revenue Opportunity, Competitive Analysis Historical Data from 2018-2024 and Forecast 2025-2033 According to FutureWise analysis, the Actigraphy Sensors and PSG Devices Market in 2025 is US$1.32 billion, and is expected to reach US$2.58 billion by 2033 at a CAGR of 8.74%. The market for actigraphy sensors and polysomnography (PSG) devices is experiencing an impressive surge, fueled by a rise in sleep disorders like insomnia, sleep apnea, and narcolepsy. What’s exciting is the game-changing fusion of artificial intelligence (AI) and the Internet of Things (IoT) in sleep monitoring technology; it’s revolutionizing the way we diagnose and understand sleep health. As consumers become more health-conscious and technology continues to advance—enabling the miniaturization of devices—we are witnessing a ... Continue reading →

According to FutureWise analysis, the Nanobodies market in 2025 is US$0.61 billion, and is expected to reach US$2.29 billion by 2033 at a CAGR of 17.98%. The nanobody market is experiencing rapid growth due to their unique properties, including small size, high stability, and strong binding affinity. This significant increase in the use of nanobodies highlights their growing acceptance in therapeutic and diagnostic applications. These tiny antibody fragments offer distinct advantages such as improved tissue penetration, enhanced stability, and cost-effective production. As a result, pharmaceutical companies and research institutions are investing heavily in the development of nanobody-based drugs. With the ongoing evolution of precision medicine, nanobodies are poised to revolutionize treatment methods for cancer, autoimmune diseases, and infectious diseases. Their characteristics make them particularly suitable for targeted therapies and diagnostics. Additionally, ... Continue reading →

According to FutureWise analysis, the Platelet Rich Plasma Market in 2025 is US$0.76 billion, and is expected to reach US$2.20 billion by 2033 at a CAGR of 14.21%. The remarkable surge in the Platelet Rich Plasma Market market can be attributed to the growing demand for minimally invasive regenerative medicine solutions in fields such as orthopedics, dermatology, and sports medicine. Both patients and medical practitioners are increasingly turning to PRP (platelet-rich plasma) therapy, attracted by its potential for natural healing in areas like hair restoration, facial rejuvenation, and alleviating joint pain. As technological innovations in PRP preparation continue to emerge, along with a wealth of clinical evidence supporting its effectiveness, the appeal of these treatments is spreading rapidly around the globe. This exciting trend signifies a shift towards more holistic approaches in healthcare, making it an exhilarating time for both providers and recipients of these ... Continue reading →

According to FutureWise analysis, the European Antimicrobial Susceptibility Testing market in 2025 is US$4.67 billion and is expected to reach US$7.15 billion by 2033, at a CAGR of 5.47%. The European Antimicrobial Susceptibility Testing (AST) market is on the rise, fueled by the urgent challenge of antimicrobial resistance (AMR) that is increasingly affecting healthcare systems. As the demand for swift and precise diagnostic tools skyrockets, this market has become a hotspot for innovation. The advent of automated and molecular-based AST technologies is transforming how we tackle infections, making it easier than ever to pinpoint the right treatment. Government initiatives are stepping up as strong allies in this battle, emphasizing the importance of effective infection control measures. Coupled with rising healthcare expenditures and a growing emphasis on personalized medicine, there are ample opportunities for industry leaders to make a significant impact.At its ... Continue reading →

According to FutureWise analysis, the Pharmaceutical Spray Drying Market in 2025 is US$2.32 billion and is expected to reach US$4.51 billion by 2033, at a CAGR of 8.66%.The European Antimicrobial Susceptibility Testing (AST) market is on the rise, fueled by the urgent challenge of antimicrobial resistance (AMR) that is increasingly affecting healthcare systems. As the demand for swift and precise diagnostic tools skyrockets, this market has become a hotspot for innovation. The advent of automated and molecular-based AST technologies is transforming how we tackle infections, making it easier than ever to pinpoint the right treatment. Government initiatives are stepping up as strong allies in this battle, emphasizing the importance of effective infection control measures. Coupled with rising healthcare expenditures and a growing emphasis on personalized medicine, there are ample opportunities for industry leaders to make a significant impact.At its core, antimicrobial ... Continue reading →

According to FutureWise analysis, the cell cryopreservation market in 2025 is US$13.68 billion, and is expected to reach US$70.35 billion by 2033 at a CAGR of 22.71%. The cell cryopreservation market is experiencing significant growth, primarily driven by the increasing demand for cell-based therapies, stem cell banking, and regenerative medicine. This expansion can be attributed to a rising interest in stem cell therapies and biobanking, complemented by increased investments in research and development. Notable advancements in cryopreservation technologies are also playing a critical role in supporting market growth. As the demand for cell-based therapeutics and personalized medicine continues to rise, substantial opportunities are emerging for stakeholders on a global scale. The biotechnology and pharmaceutical sectors are ramping up research and development activities, further boosting market expansion. Additionally, the growing adoption of biobanking and personalized medicine ... Continue reading →

According to FutureWise analysis, the PSA test market in 2025 is US$4.23 billion and is expected to reach US$8.05 billion by 2033, at a CAGR of 8.28%. The growth of the prostate-specific antigen (PSA) test market is primarily driven by increasing awareness of prostate cancer screening and advancements in diagnostic technologies. The rising prevalence of prostate-related disorders among aging populations is also contributing to demand. Additionally, the expansion of healthcare infrastructure and the adoption of early detection practices in emerging economies are expected to significantly enhance market growth. The PSA test, a blood test used mainly for screening prostate cancer, checks for prostate-specific antigen (PSA) levels in the blood. PSA is a protein produced by both cancerous and noncancerous cells in the prostate gland, which lies just below the bladder in men. While a small amount of PSA is normally present in the blood, elevated levels may indicate the presence of prostate ... Continue reading →